All In Biotech

Free tool

FAERS Monitor: Accrufer

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212320 or its brand name (Accrufer, Ferric Maltol). Reports on generic versions are filed under their own applications.

Reports

1,060

Serious

214

20% of reports

Hospitalization

87

Death reported

42

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • constipation160
  • inappropriate schedule of product administration108
  • abdominal discomfort104
  • diarrhoea103
  • nausea99
  • abdominal pain upper75
  • maternal exposure during pregnancy71
  • treatment noncompliance61
  • drug ineffective51
  • off label use42
  • death39
  • vomiting34
  • dizziness27
  • faeces discoloured23
  • fatigue23

Reports by year received

View as table
YearReports
20161
20182
20192
20203
20217
202235
202393
2024272
2025576
202669

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,099 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
treatment noncomplianceSignal6122.117.41,213
faeces discolouredSignal2321.114.1420
maternal exposure during pregnancySignal7115.812.6974
constipationSignal16014.612.62,028
abdominal discomfortSignal10412.310.31,077
inappropriate schedule of product administrationSignal10811.99.91,076
abdominal pain upperSignal757.25.8400
diarrhoeaSignal1033.22.6155
nauseaSignal992.52.190
vomiting341.41.04
dizziness271.10.70
off label use421.00.70
death390.90.70
drug ineffective510.80.64
fatigue230.60.47

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.